Stek M - Search Results

1

Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.

Arnaiz JA, Mallolas J, Podzamczer D, Gerstoft J, Lundgren JD, Cahn P, Fätkenheuer G, D'Arminio-Monforte A, Casiró A, Reiss P, Burger DM, Stek M, Gatell JM; BEST Study Team. Arnaiz JA, et al. Among authors: stek m. AIDS. 2003 Apr 11;17(6):831-40. doi: 10.1097/00002030-200304110-00008. AIDS. 2003. PMID: 12660530 Clinical Trial.

2

Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patients.

Aarnoutse RE, Brinkman K, Benetucci J, Begovac J, Stek M Jr, Burger DM. Aarnoutse RE, et al. Among authors: stek m jr. AIDS. 2004 Feb 20;18(3):565-7. doi: 10.1097/00002030-200402200-00026. AIDS. 2004. PMID: 15090812

3

The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.

Aarnoutse RE, Grintjes KJ, Telgt DS, Stek M Jr, Hugen PW, Reiss P, Koopmans PP, Hekster YA, Burger DM. Aarnoutse RE, et al. Among authors: stek m jr. Clin Pharmacol Ther. 2002 Jan;71(1):57-67. doi: 10.1067/mcp.2002.121424. Clin Pharmacol Ther. 2002. PMID: 11823758 Clinical Trial.

4

Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients.

Burger D, Boyd M, Duncombe C, Felderhof M, Mahanontharit A, Ruxrungtham K, Ubolyam S, Stek M, Cooper D, Lange J, Phanupak P, Reiss P. Burger D, et al. Among authors: stek m. J Antimicrob Chemother. 2003 May;51(5):1231-8. doi: 10.1093/jac/dkg198. Epub 2003 Mar 28. J Antimicrob Chemother. 2003. PMID: 12668574 Clinical Trial.

5

Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects.

Boyd MA, Aarnoutse RE, Ruxrungtham K, Stek M Jr, van Heeswijk RP, Lange JM, Cooper DA, Phanuphak P, Burger DM. Boyd MA, et al. Among authors: stek m jr. J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):134-9. doi: 10.1097/00126334-200310010-00003. J Acquir Immune Defic Syndr. 2003. PMID: 14526202

6

Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).

Boyd MA, Srasuebkul P, Khongphattanayothin M, Ruxrungtham K, Hassink EA, Duncombe CJ, Ubolyam S, Burger DM, Reiss P, Stek M Jr, Lange J, Cooper DA, Phanuphak P. Boyd MA, et al. Among authors: stek m jr. Antivir Ther. 2006;11(2):223-32. Antivir Ther. 2006. PMID: 16640103 Clinical Trial.

7

Dose-finding study of a once-daily indinavir/ritonavir regimen.

Hugen PW, Burger DM, ter Hofstede HJ, Koopmans PP, Stek M, Hekster YA, Reiss P, Lange JM. Hugen PW, et al. Among authors: stek m. J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):236-45. doi: 10.1097/00126334-200011010-00005. J Acquir Immune Defic Syndr. 2000. PMID: 11115954 Clinical Trial.

8

A once-daily HAART regimen containing indinavir + ritonavir plus one or two nucleoside reverse transcriptase inhibitors (PIPO study).

Burger DM, Aarnoutse RE, Dieleman JP, Gyssens IC, Nouwen J, de Marie S, Koopmans PP, Stek M Jr, van der Ende ME. Burger DM, et al. Among authors: stek m jr. Antivir Ther. 2003 Oct;8(5):455-61. Antivir Ther. 2003. PMID: 14640393 Clinical Trial.

9

Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.

Casula M, Weverling GJ, Wit FW, Timmermans EC, Stek M Jr, Lange JM, Reiss P. Casula M, et al. Among authors: stek m jr. J Infect Dis. 2005 Nov 15;192(10):1794-800. doi: 10.1086/497140. Epub 2005 Oct 12. J Infect Dis. 2005. PMID: 16235179 Clinical Trial.

10

Pharmacokinetic interaction study of indinavir/ritonavir and the enteric-coated capsule formulation of didanosine in healthy volunteers.

la Porte C, Verweij-van Wissen C, van Ewijk N, Aarnoutse R, Koopmans P, Reiss P, Stek M Jr, Hekster Y, Burger D. la Porte C, et al. Among authors: stek m jr. J Clin Pharmacol. 2005 Feb;45(2):211-8. doi: 10.1177/0091270004271063. J Clin Pharmacol. 2005. PMID: 15647414 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page